MEDICAL SCIENCE LIAISON- ONCOLOGY
Pubblicato il 09-09-2026 - Recordati in Milano
At Recordati, we are united by a clear purpose: unlocking the full potential of life. With a century of history behind us, we are building the next chapter of our journey, continuing to grow while keeping patients at the centre of all we do.
What drives us is a shared belief that health, and the opportunity to live life to the full, should be within reach for everyone. This brings energy to our work, shaping how we support each other and show up every day. Above all, these values bring to life our promise to everyone at Recordati, you can unlock your full potential. We know that people thrive when they can be themselves, are trusted and supported, and are given the opportunity to grow and make a meaningful contribution.
The Medical Science Liaison, reporting to the Medical Director RRD Italy, serves as the primary scientific interface for the Rare Diseases affiliate in Italy, operating within the pediatric oncology therapeutic area with a specific focus on neuroblastoma, and supporting high‑quality scientific exchange, medical education,
and field insight generation in a highly complex clinical setting.
Conduct high-quality, timely peer-to-peer scientific exchanges with healthcare professionals, ensuring accurate and balanced communication of scientific data in full compliance with company policies and legal/ethical standards.
Serve as a trusted scientific partner for clinicians, providing advanced medical and scientific education, addressing complex clinical questions, and responding to unsolicited requests for information related to disease management and company products.
Deliver high-level medical education tailored to healthcare professionals’ needs, ensuring scientific rigor and supporting evidence-based clinical decision making in pediatric oncology.
Act as the medical reference in the field for internal teams and external stakeholders (physicians, pharmacists, institutions), providing expert medical insight on disease area and products.
Maintain conti